Intensity Therapeutics | 8-K: Current report
Intensity Therapeutics | 8-K: Intensity Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update
Intensity Therapeutics | 8-K: Current report
Intensity Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Intensity Therapeutics | S-3: Registration statement for specified transactions by certain issuers
Intensity Therapeutics | 8-K: Current report
Intensity Therapeutics | S-3: Registration statement for specified transactions by certain issuers
Intensity Therapeutics | DEF 14A: Definitive information statements
Intensity Therapeutics | DEFA14A: Others
Intensity Therapeutics | 8-K: Current report
Intensity Therapeutics | 8-K: Current report
Intensity Therapeutics | 8-K: Current report
Intensity Therapeutics | 8-K: Intensity Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
Intensity Therapeutics | 8-K: Current report
Intensity Therapeutics | 8-K: Current report
Intensity Therapeutics | 8-K: Current report
Intensity Therapeutics | 8-K: Current report
Intensity Therapeutics | 8-K: Current report
Intensity Therapeutics | 8-K: Intensity Therapeutics Reports Third Quarter Financial Results and Provides Corporate Update
Intensity Therapeutics | 8-K: Current report
No Data
No Data